There is an increasing amount of evidence that Pfizer-BioNTech’s and Moderna’s mRNA vaccines don’t work as well against B.1.617, the variant responsible for India’s recent outbreak. China’s Jan-Apr thermal power generation rose +12% compared to the same period two years ago, despite a tepid consumer recovery.
Monday morning links
There is an increasing amount of evidence that Pfizer-BioNTech’s and Moderna’s mRNA vaccines don’t work as well against B.1.617, the variant responsible for India’s recent outbreak. China’s Jan-Apr thermal power generation rose +12% compared to the same period two years ago, despite a tepid consumer recovery.
Create your profile
Only paid subscribers can comment on this post
Check your email
For your security, we need to re-authenticate you.
Click the link we sent to , or click here to sign in.